+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Probing the non-proline cis peptide bond in beta-lactamase from Staphylococcus aureus PC1 by the replacement Asn136 --> Ala

Probing the non-proline cis peptide bond in beta-lactamase from Staphylococcus aureus PC1 by the replacement Asn136 --> Ala

Biochemistry 36(36): 10857-10866

A non-proline cis peptide is present between Glu166 and Ile167 in the active site of beta-lactamase from Staphylococcus aureus PC1. To examine the role of the interaction between the side chain of Asn136 and the main chain of Glu166, the site-directed mutant N136A was produced. The enzyme shows no measurable hydrolytic activity toward a variety of penicillins or cephalosporins except for the chromogenic cephalosporin, nitrocefin. For nitrocefin, the progress curve exhibits a fast burst with a stoichiometry of 1 mol of degraded substrate per mole of enzyme followed by a slow phase with a hydrolysis rate that is reduced by approximately 700-fold compared with that of the wild-type enzyme. Thus, the mutant enzyme is deacylation defective. Monitoring the hydrolysis of nitrocefin after preincubation with a number of beta-lactam compounds shows that cephalosporins form stable acyl complexes with the enzyme, whereas penicillins do not. The molecular weight of the mutant was determined by electrospray mass spectrometry, and the presence of the stable acyl enzyme adducts with cephaloridine and cefotaxime was confirmed by both electrospray and MALDI mass spectrometry. Therefore, in addition to impairing deacylation, the acylation machinery has been altered compared with the wild-type enzyme to act on cephalosporins and not on penicillins. Urea denaturation and thermal unfolding studies show that the N136A mutant enzyme is less stable than the wild-type enzyme. However, stability against chemical denaturation of the mutant enzyme is enhanced in the presence of cephaloridine beyond the stability of the wild-type protein. This is attributed to accumulation of favorable interactions between the cephaloridine and the protein, which play a role in the folded state and not in the unfolded state.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 047080010

Download citation: RISBibTeXText

PMID: 9283075

DOI: 10.1021/bi970352r

Related references

Probing the non-proline cis peptide bond in b-lactamase from Staphylococcus aureus PC1 by the replacement Asn136 - > Ala. Biochemistry (American Chemical Society) 36: 857-66, 1997

The slow step of folding of Staphylococcus aureus PC1 beta-lactamase involves the collapse of a surface loop rate limited by the trans to cis isomerization of a non-proline peptide bond. Proteins 33(4): 550-557, 1998

The rate-limiting step in the folding of the cis-Pro167Thr mutant of TEM-1 beta-lactamase is the trans to cis isomerization of a non-proline peptide bond. Proteins 25(1): 104-111, 1996

Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations. Journal of Antimicrobial ChemoTherapy 32(3): 431-444, 1993

Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and Virulence. Plos one 10(8): E0136605, 2015

Nucleotide sequence and expression of the beta-lactamase gene from Staphylococcus aureus plasmid pI258 in Escherichia coli, Bacillus subtilis, and Staphylococcus aureus. Journal of Bacteriology 169(4): 1763-1766, 1987

beta-Lactamase production and genetic location in Staphylococcus aureus: introduction of a beta-lactamase plasmid in strains of phage group II. Journal of Hospital Infection 30(2): 111-124, 1995

beta-Lactamase types amongst Staphylococcus aureus isolates in relation to susceptibility to beta-lactamase inhibitor combinations. Journal of Antimicrobial ChemoTherapy 33(3): 465-481, 1994

In vitro activity of N-formimidoyl thienamycin (MK 0787) compared with other beta-lactamase stable cephalosporins against beta-lactamase producing Staphylococcus aureus. Indian Journal of Medical Research 79: 482-486, 1984

Effects of sulfate and urea on the stability and reversible unfolding of beta lactamase from staphylococcus aureus implications for the folding pathway of beta lactamase. Journal of Molecular Biology 184(2): 331-342, 1985

Pre-steady state beta-lactamase kinetics. Observation of a covalent intermediate during turnover of a fluorescent cephalosporin by the beta-lactamase of STaphylococcus aureus PC1. Journal of Biological Chemistry 256(22): 11401-4, 1981

Sequence analysis of the beta-lactamase repressor from Staphylococcus aureus and hybridization studies with two beta-lactamase-producing isolates of Enterococcus faecalis. Antimicrobial Agents and ChemoTherapy 36(10): 2265-2269, 1992

The regulation of both beta lactamase and pbp2a production in methicillin resistant staphylococcus aureus mrsa involves two genes found upstream of the beta lactamase gene blaz. Abstracts of the General Meeting of the American Society for Microbiology 92: 21, 1992

The beta-lactamase activity in methicillin-resistant Staphylococcus aureus--a comparison of the beta-lactamase from a methicillin-resistant and from a methicillin-sensitive strain of Staphylococcus aureus. Nihon Rinsho. Japanese Journal of Clinical Medicine 50(5): 1049-1053, 1992

Redefining the Role of the beta-Lactamase Locus in Methicillin-Resistant Staphylococcus aureus beta-Lactamase Regulators Disrupt the MecI-Mediated Strong Repression on mecA and Optimize the Phenotypic Expression of Resistance in Strains with Constitu. 2013